DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Valcyte (Valganciclovir) - Cytomegalovirus Infection - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cytomegalovirus Infection (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Valcyte (Valganciclovir) where reactions include cytomegalovirus infection. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Valcyte side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-13

Patient: male

Reactions: Cytomegalovirus Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Valcyte



Possible Valcyte side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-03

Patient: male

Reactions: Cytomegalovirus Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Valcyte



Possible Valcyte side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient:

Reactions: Neuropathy Peripheral, Viral Infection, Fungal Infection, Cytomegalovirus Infection, Bacterial Infection, Leukopenia

Drug(s) suspected as cause:
Basiliximab
    Indication: Immunosuppression

Cellcept
    Administration route: Oral
    Indication: Immunosuppression

Prednisone
    Dosage: by 2 years post transplant

Prednisone
    Indication: Immunosuppression

Tacrolimus
    Dosage: first 3 months 14 ng/ml
    Indication: Immunosuppression

Tacrolimus
    Dosage: thereafter adjusted to 8-12 ng/ml

Valcyte
    Administration route: Oral
    Indication: Antiviral Prophylaxis



Possible Valcyte side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-20

Patient: male

Reactions: Malaise, Cytomegalovirus Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Valcyte



Possible Valcyte side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04

Patient: female, weighing 51.8 kg (114.0 pounds)

Reactions: Viral Infection, Anaemia, Cytomegalovirus Infection, Bacterial Infection, Toxicity To Various Agents

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prograf
    Dosage: 1mg; up to 8mg bid po
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-09-01
    End date: 2012-04-11

Valcyte
    Dosage: 450mg od po
    Administration route: Oral
    Start date: 2011-09-01



Possible Valcyte side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-08

Patient: female, weighing 102.6 kg (225.7 pounds)

Reactions: Diarrhoea, Cytomegalovirus Infection, Leukopenia

Drug(s) suspected as cause:
Valcyte

Other drugs received by patient: Prednisone TAB; Mycophenolate Mofetil



Possible Valcyte side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-14

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Brain Herniation, Cytomegalovirus Infection, Diarrhoea Infectious

Adverse event resulted in: death

Drug(s) suspected as cause:
Mycophenolate Mofetil (Cellcept)
    Administration route: Oral

Mycophenolate Mofetil (Cellcept)
    Indication: Product Used FOR Unknown Indication

Valcyte
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Hydrochlorothiazide; Valsartan; Prednisone TAB; Phenytoin; Calcium D3; Prograf; Acetaminophen; Hydrocodone Bitartrate and Acetaminophen; Bactrim; Metoprolol Succinate; Magnesium; Cyclosporine; Prilosec



Possible Valcyte side effects in

Reported by a individual with unspecified qualification from Spain on 2012-02-23

Patient:

Reactions: Drug Resistance, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Ganciclovir Sodium
    Indication: Antiviral Prophylaxis

Valcyte
    Administration route: Oral
    Indication: Antiviral Prophylaxis



Possible Valcyte side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-09

Patient:

Reactions: Drug Resistance, Cytomegalovirus Infection, Treatment Failure

Drug(s) suspected as cause:
Cyclosporine
    Indication: Prophylaxis Against Transplant Rejection

Mycophenolate Mofetil (Cellcept)
    Indication: Prophylaxis Against Transplant Rejection

Tacrolimus
    Indication: Prophylaxis Against Transplant Rejection

Valcyte
    Administration route: Oral
    Indication: Antiviral Prophylaxis



Possible Valcyte side effects in 78 year old female

Reported by a consumer/non-health professional from United States on 2012-01-24

Patient: 78 year old female

Reactions: Colitis Ulcerative, Cytomegalovirus Infection, Bursitis, Rash Pruritic

Drug(s) suspected as cause:
Prolia
    Dosage: 60 mg, unk
    Indication: Osteoporosis Postmenopausal
    Start date: 2011-02-01

Valcyte
    Dosage: unk
    Indication: Cytomegalovirus Infection
    Start date: 2011-05-01
    End date: 2011-01-01

Other drugs received by patient: Asacol; Plavix; Oxybutynin; Acyclovir; Dermatologicals; Metoprolol Tartrate; Prednisolone; Levothyroxine Sodium; Celluvisc; Varicella-Zoster Immune Globulin (Human); Multi-Vitamins



Possible Valcyte side effects in female

Reported by a physician from Finland on 2011-12-29

Patient: female

Reactions: Anaemia, Hepatic Enzyme Increased, Interstitial Lung Disease, Diarrhoea, Staphylococcal Infection, Aspergillosis, Cytomegalovirus Infection, Neutropenia, Blood Creatinine Increased, Sinusitis, Thrombocytopenia, Soft Tissue Neoplasm, Herpes Virus Infection, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Alemtuzumab
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Fludarabine Phosphate
    Indication: Chronic Lymphocytic Leukaemia

Foscavir
    Indication: Cytomegalovirus Infection

Mabthera
    Indication: Chronic Lymphocytic Leukaemia

Valcyte
    Administration route: Oral
    Indication: Cytomegalovirus Infection
    Start date: 2010-04-26

Other drugs received by patient: Cyclosporine; Fluconazole; Emgesan; Valtrex; Ratiograstim; Lansoprazole; Prednisone TAB; Neulasta; Ceftazidime; Ribavirin; Hydrocortisone; Gensumycin; Ditrim Duplo; Multitabs; Calcium Carbonate; Adursal; Avelox; Tenox; Ceftriaxone; Mycophenolate Mofetil (Cellcept); Vitamin C; Ceftazidime; Medrol; Pulmicort; Zithromax; Diflucan



Possible Valcyte side effects in 62 year old male

Reported by a individual with unspecified qualification from Germany on 2011-11-29

Patient: 62 year old male

Reactions: Pneumonia, Diarrhoea, Benign Prostatic Hyperplasia, Cytomegalovirus Infection, Transplant Rejection, Pyelonephritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mycophenolate Mofetil (Cellcept)
    Start date: 2008-05-23
    End date: 2008-05-23

Mycophenolate Mofetil (Cellcept)

Mycophenolate Mofetil (Cellcept)
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-04-14
    End date: 2008-05-15

Tacrolimus
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-05-10
    End date: 2008-05-15

Tacrolimus
    Start date: 2008-05-20
    End date: 2008-05-20

Tacrolimus

Tacrolimus
    Start date: 2008-05-16
    End date: 2008-05-16

Tacrolimus
    Start date: 2008-05-17
    End date: 2008-05-18

Tacrolimus
    Start date: 2008-05-15
    End date: 2008-05-15

Tacrolimus

Tacrolimus
    Start date: 2008-05-19
    End date: 2008-05-19

Valcyte
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Other drugs received by patient: Neurontin; Amphotericin B; Pantoprazole; Metoprolol Tartrate; Antirheumatic Agent NOS; Prednisone TAB; Repaglinide; Actraphane; Cotrim DS; Neorecormon; Prednisone TAB; Avandia; Torsemide; Tamsulosin HCL; Ciprofloxacin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017